Peter Verheesen

1.1k total citations
21 papers, 794 citations indexed

About

Peter Verheesen is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Pathology and Forensic Medicine. According to data from OpenAlex, Peter Verheesen has authored 21 papers receiving a total of 794 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 11 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Peter Verheesen's work include Monoclonal and Polyclonal Antibodies Research (11 papers), Glycosylation and Glycoproteins Research (6 papers) and Autoimmune Bullous Skin Diseases (6 papers). Peter Verheesen is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (11 papers), Glycosylation and Glycoproteins Research (6 papers) and Autoimmune Bullous Skin Diseases (6 papers). Peter Verheesen collaborates with scholars based in Netherlands, Belgium and Germany. Peter Verheesen's co-authors include Hans de Haard, C. Theo Verrips, E. Sally Ward, Peter Ulrichts, Silvère M. van der Maarel, Antonio Guglietta, Erik Hofman, F. Javier Enriquez, Valérie Hanssens and Nicolas Leupin and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and The Journal of Immunology.

In The Last Decade

Peter Verheesen

21 papers receiving 785 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter Verheesen Netherlands	13	357	296	168	155	119	21	794
William Siders United States	15	274 0.8×	86 0.3×	77 0.5×	472 3.0×	248 2.1×	26	875
Purnima Sundar United States	14	490 1.4×	471 1.6×	108 0.6×	668 4.3×	247 2.1×	15	1.2k
Dilduz Telman United States	6	354 1.0×	389 1.3×	71 0.4×	429 2.8×	237 2.0×	6	817
Gabriella Huerta United States	5	320 0.9×	325 1.1×	41 0.2×	410 2.6×	139 1.2×	5	736
Harry F. Abts Germany	16	299 0.8×	50 0.2×	23 0.1×	248 1.6×	143 1.2×	27	818
J.R. Selden United States	15	469 1.3×	33 0.1×	54 0.3×	58 0.4×	56 0.5×	25	804
Brad Stone United States	13	279 0.8×	80 0.3×	93 0.6×	293 1.9×	16 0.1×	29	700
Mark J. Kwakkenbos Netherlands	18	661 1.9×	259 0.9×	9 0.1×	568 3.7×	50 0.4×	22	1.4k
Hiroyuki Gonda Japan	14	468 1.3×	50 0.2×	34 0.2×	997 6.4×	54 0.5×	18	1.5k
Caroline Grygar France	10	179 0.5×	55 0.2×	69 0.4×	566 3.7×	29 0.2×	12	1.0k

Countries citing papers authored by Peter Verheesen

Since Specialization

Citations

This map shows the geographic impact of Peter Verheesen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Verheesen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Verheesen more than expected).

Fields of papers citing papers by Peter Verheesen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Verheesen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Verheesen. The network helps show where Peter Verheesen may publish in the future.

Co-authorship network of co-authors of Peter Verheesen

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Verheesen. A scholar is included among the top collaborators of Peter Verheesen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Verheesen. Peter Verheesen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bao, Lei, Bethany E. Perez White, Peter Verheesen, et al.. (2024). Neonatal Fc Receptor Inhibition Reduces Bullous Pemphigoid Anti–Basement Membrane Zone IgG Deposition and Blistering in 3-Dimensional Human Skin Equivalents. Journal of Investigative Dermatology. 144(12). 2809–2812.e2. 4 indexed citations

Vassileva, Snejina, Dédée F. Murrell, Donna A. Culton, et al.. (2024). Overview of Clinical Trials With Efgartigimod in Autoimmune Blistering Diseases: Pemphigus Vulgaris and Pemphigus Foliaceus (ADDRESS and ADDRESS+) and Bullous Pemphigoid (BALLAD and BALLAD+). SKIN The Journal of Cutaneous Medicine. 8(1). s345–s345. 1 indexed citations

Ostrovskaya, Olga, et al.. (2023). Efgartigimod: Clinical Development of a Novel FcRn Antagonist in the Treatment of Autoimmune Diseases. SKIN The Journal of Cutaneous Medicine. 7(2). s193–s193. 1 indexed citations

Pigors, Manuela, Shirin Emtenani, Katja Bieber, et al.. (2023). Bullous pemphigoid induced by IgG targeting type XVII collagen non‐NC16A / NC15A extracellular domains is driven by Fc gamma receptor‐ and complement‐mediated effector mechanisms and is ameliorated by neonatal Fc receptor blockade. The Journal of Pathology. 262(2). 161–174. 12 indexed citations

Brinkhaus, Maximilian, Arthur E. H. Bentlage, Ninotska I. L. Derksen, et al.. (2022). The Fab region of IgG impairs the internalization pathway of FcRn upon Fc engagement. Nature Communications. 13(1). 6073–6073. 27 indexed citations

Maho‐Vaillant, Maud, Magdalena Sips, Marie-Laure Golinski, et al.. (2022). FcRn Antagonism Leads to a Decrease of Desmoglein-Specific B Cells: Secondary Analysis of a Phase 2 Study of Efgartigimod in Pemphigus Vulgaris and Pemphigus Foliaceus. Frontiers in Immunology. 13. 863095–863095. 26 indexed citations

Zakrzewicz, Anna, Stian Foss, Jan Terje Andersen, et al.. (2022). Stabilization of Keratinocyte Monolayer Integrity in the Presence of Anti-Desmoglein-3 Antibodies through FcRn Blockade with Efgartigimod: Novel Treatment Paradigm for Pemphigus?. Cells. 11(6). 942–942. 17 indexed citations

Brinkhaus, Maximilian, Arthur E. H. Bentlage, Steven W. de Taeye, et al.. (2020). Glycine 236 in the Lower Hinge Region of Human IgG1 Differentiates FcγR from Complement Effector Function. The Journal of Immunology. 205(12). 3456–3467. 11 indexed citations

Ulrichts, Peter, Antonio Guglietta, Torsten Dreier, et al.. (2018). Neonatal Fc receptor antagonist efgartigimod safely and sustainably reduces IgGs in humans. Journal of Clinical Investigation. 128(10). 4372–4386. 251 indexed citations

10.

Coninck, Barbara De, Peter Verheesen, Christine M. F. Vos, et al.. (2017). Fungal Glucosylceramide-Specific Camelid Single Domain Antibodies Are Characterized by Broad Spectrum Antifungal Activity. Frontiers in Microbiology. 8. 1059–1059. 13 indexed citations

11.

Zwertvaegher, Ingrid, et al.. (2016). Development and implementation of a laboratory spray device and rainfall simulator for retention research using small amounts of agroformulations. Pest Management Science. 73(1). 123–129. 5 indexed citations

12.

Verheesen, Peter & Toon Laeremans. (2012). Selection by Phage Display of Single Domain Antibodies Specific to Antigens in Their Native Conformation. Methods in molecular biology. 911. 81–104. 12 indexed citations

13.

Klooster, Rinse, et al.. (2008). Selection and characterization of KDEL-specific VHH antibody fragments and their application in the study of ER resident protein expression. Journal of Immunological Methods. 342(1-2). 1–12. 23 indexed citations

14.

Verheesen, Peter, Andreas Roussis, Hans J. de Haard, et al.. (2006). Reliable and controllable antibody fragment selections from Camelid non-immune libraries for target validation. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1764(8). 1307–1319. 55 indexed citations

15.

Groot, Arjan J., Peter Verheesen, Eelke Gort, et al.. (2006). Identification by phage display of single-domain antibody fragments specific for the ODD domain in hypoxia-inducible factor 1alpha. Laboratory Investigation. 86(4). 345–356. 33 indexed citations

16.

Verheesen, Peter, Anna de Kluijver, Silvana van Koningsbruggen, et al.. (2006). G.P.9 01 Prevention of oculopharyngeal muscular dystrophy-associated aggregation of nuclear poly(A)-binding protein with an intracellularly expressed camelid-derived antibody domain. Neuromuscular Disorders. 16(9-10). 710–711. 2 indexed citations

17.

Huang, Yanchao, Peter Verheesen, Andreas Roussis, et al.. (2005). Protein studies in dysferlinopathy patients using llama-derived antibody fragments selected by phage display. European Journal of Human Genetics. 13(6). 721–730. 52 indexed citations

18.

Verheesen, Peter, Anna de Kluijver, Silvana van Koningsbruggen, et al.. (2005). Prevention of oculopharyngeal muscular dystrophy-associated aggregation of nuclear poly(A)-binding protein with a single-domain intracellular antibody. Human Molecular Genetics. 15(1). 105–111. 64 indexed citations

19.

Regan‐Klapisz, Elsa, Irina Sorokina, Jarno Voortman, et al.. (2005). Ubiquilin recruits Eps15 into ubiquitin-rich cytoplasmic aggregates via a UIM-UBL interaction. Journal of Cell Science. 118(19). 4437–4450. 57 indexed citations

20.

Verheesen, Peter, et al.. (2003). Beneficial properties of single-domain antibody fragments for application in immunoaffinity purification and immuno-perfusion chromatography. Biochimica et Biophysica Acta (BBA) - General Subjects. 1624(1-3). 21–28. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact